Comparison

Enasidenib European Partner

Item no. M4945-100mg
Manufacturer AbMole
CASRN 1446502-11-9
Amount 100mg
Category
Type Inhibitors
Specific against other
Purity >99.0%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias AG-221
Available
Target Information
Dehydrogenase
Molecular Weight
473, 37
Solubility
DMSO 40 mg/mL
Bioactivity information
Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close